Abstract
Breast cancers are highly variable with regard to pathological and clinical features. While various different cancers being at different stages of tumor progression might explain some of this variability, we must also consider evidence that breast cancers can also develop along different molecular pathways. This manuscript discusses the extensive heterogeneity of breast cancer at the pathological and molecular level, reviewing evidence for a breast cancer progression model as well as evidence that breast cancer is not a single disease. In addition to this heterogeneity among different breast cancers, there is often pathological and molecular heterogeneity among different areas within individual neoplasms. This heterogeneity within cancers probably reflects genetic instability, and could also explain the ability of breast cancers to adapt to new environmental situations. Understanding this heterogeneity, among different breast cancers as well as within individual cancers, is important for understanding the complexity of this disease and ultimately for managing breast cancer effectively.
Current Genomics
Title: Heterogeneity in the Pathology and Molecular Biology of Breast Cancer
Volume: 3 Issue: 5
Author(s): Edward Gabrielson and Pedram Argani
Affiliation:
Abstract: Breast cancers are highly variable with regard to pathological and clinical features. While various different cancers being at different stages of tumor progression might explain some of this variability, we must also consider evidence that breast cancers can also develop along different molecular pathways. This manuscript discusses the extensive heterogeneity of breast cancer at the pathological and molecular level, reviewing evidence for a breast cancer progression model as well as evidence that breast cancer is not a single disease. In addition to this heterogeneity among different breast cancers, there is often pathological and molecular heterogeneity among different areas within individual neoplasms. This heterogeneity within cancers probably reflects genetic instability, and could also explain the ability of breast cancers to adapt to new environmental situations. Understanding this heterogeneity, among different breast cancers as well as within individual cancers, is important for understanding the complexity of this disease and ultimately for managing breast cancer effectively.
Export Options
About this article
Cite this article as:
Gabrielson Edward and Argani Pedram, Heterogeneity in the Pathology and Molecular Biology of Breast Cancer, Current Genomics 2002; 3 (5) . https://dx.doi.org/10.2174/1389202023350327
DOI https://dx.doi.org/10.2174/1389202023350327 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Reduction of Breast Cancer Relapses with Perioperative Non-Steroidal Anti-Inflammatory Drugs: New Findings and a Review
Current Medicinal Chemistry RNA Interference: New Therapeutics in Allergic Diseases
Current Gene Therapy Smart Nanocarriers for Targeted Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Atrial Fibrillation Recurrence: The Roles of Hypertension, Duration of Atrial Fibrillation Disease, and Prolonged Signal-Averaged P Wave Duration
Current Cardiology Reviews Targeting of Hsp32 in Solid Tumors and Leukemias: A Novel Approach to Optimize Anticancer Therapy (Supplementry Material)
Current Cancer Drug Targets γ-Secretase Substrates and their Implications for Drug Development in Alzheimer's Disease
Current Topics in Medicinal Chemistry Preparation and Surface Modification of Polymeric Nanoparticles for Drug Delivery: State of the Art
Recent Patents on Drug Delivery & Formulation The Expression, Function and Targeting of Haem Oxygenase-1 in Cancer
Current Cancer Drug Targets Targeting Trail Towards the Clinic
Current Drug Targets Targeting the Ubiquitin-Proteasome Pathway in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Targeting Chk2 Kinase: Molecular Interaction Maps and Therapeutic Rationale
Current Pharmaceutical Design Targeting Carcinogen Metabolism by Dietary Cancer Preventive Compounds
Current Cancer Drug Targets Isoindole Derivatives: Propitious Anticancer Structural Motifs
Current Topics in Medicinal Chemistry Role of Sequence Variations in <i>AhR</i> Gene Towards Modulating Smoking Induced Lung Cancer Susceptibility in North Indian Population: A Multiple Interaction Analysis
Current Genomics Meet Our Editorial Board Member
Current Green Chemistry Immunotherapy in Liver Diseases: A Balance Between Immunity and Tolerance
Current Drug Metabolism New Biomarkers for Colon Cancer Diagnosis: A Review of Recent Patents
Recent Patents on Biomarkers Expression of Angiogenesis-related Genes in a Group of Iranian Cases of Breast Cancer
Current Pharmacogenomics and Personalized Medicine Goniothalamin-Related Styryl Lactones: Isolation, Synthesis, Biological Activity and Mode of Action
Current Medicinal Chemistry Editorial Review 2015
Current Radiopharmaceuticals